Express Scripts 2013 Annual Report Download - page 117

Download and view the complete annual report

Please find page 117 of the 2013 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

117 Express Scripts 2013 Annual Report
Exhibit
No. Title
4.25 Sixth Supplemental Indenture, dated as of February 9, 2012, among Express Scripts, Inc., Express Scripts Holding
Company (formerly Aristotle Holding, Inc.), the other subsidiaries of Express Scripts Holding Company party
thereto and Wells Fargo Bank, National Association, as Trustee, related to Express Scripts Holding Company’s
2.650% senior notes due 2017, incorporated by reference to Exhibit 4.2 to Express Scripts, Inc.’s Current Report on
Form 8-K filed February 10, 2012, File No. 000-20199.
4.26 Seventh Supplemental Indenture, dated as of February 9, 2012, among Express Scripts, Inc., Express Scripts
Holding Company (formerly Aristotle Holding, Inc.), the other subsidiaries of Express Scripts Holding Company
party thereto and Wells Fargo Bank, National Association, as Trustee, related to Express Scripts Holding
Company’s 3.900% senior notes due 2022, incorporated by reference to Exhibit 4.3 to Express Scripts, Inc.’s
Current Report on Form 8-K filed February 10, 2012, File No. 000-20199.
4.27 Eighth Supplemental Indenture, dated as of April 2, 2012, among Express Scripts, Inc., Express Scripts Holding
Company, Medco Health Solutions, Inc., the other subsidiaries of Express Scripts Holding Company party thereto
and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 to Express Scripts
Holding Company’s Current Report on Form 8-K filed April 6, 2012.
4.28 Ninth Supplemental Indenture, dated as of May 29, 2012, among Express Scripts, Inc., Express Scripts Holding
Company, Medco Health Solutions, Inc., the other subsidiaries of Express Scripts Holding Company party thereto
and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 to Express Scripts
Holding Company’s Current Report on Form 8-K filed June 4, 2012.
4.29(2) Tenth Supplemental Indenture, dated as of October 21, 2013, among Express Scripts Holding Company, United
BioSource Holdings, Inc., Express Scripts Pharmacy, Inc. and Wells Fargo Bank, National Association, as Trustee.
4.30 Subsidiary Guaranty, dated as of April 2, 2012, by and among the subsidiaries of Express Scripts Holding Company
party thereto as guarantors, in favor of Credit Suisse, as supplemented by that certain counterpart dated as of May
29, 2012, incorporated by reference to Exhibit 4.4 to Express Scripts Holding Company’s Current Report on Form
8-K filed June 4, 2012.
10.1(3) Amended and Restated Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit
No. 10.1 to Express Scripts, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2001, File No.
000-20199.
10.2(3) Second Amendment to the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to
Exhibit No. 10.27 to Express Scripts, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2001,
File No. 000-20199.
10.3(3) Third Amendment to the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit
A to Express Scripts, Inc.’s Proxy Statement filed April 18, 2006, File No. 000-20199.
10.4(3) Form of Stock Option Agreement used with respect to grants of stock options by Express Scripts, Inc. under the
Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit No. 10.3 to Express
Scripts, Inc.’s Current Report on Form 8-K filed February 26, 2008, File No. 000-20199.
10.5(3) Form of Restricted Stock Agreement used with respect to grants of restricted stock by Express Scripts, Inc. under
the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit No. 10.7 to Express
Scripts, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004, File No. 000-20199.
10.6(3) Form of Performance Share Award Agreement used with respect to grants of performance shares by Express
Scripts, Inc. under the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit
No. 10.2 to Express Scripts, Inc.’s Current Report on Form 8-K filed February 26, 2008, File No. 000-20199.
10.7(3) Form of Stock Appreciation Right Award Agreement used with respect to grants of stock appreciation rights under
the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit No. 10.2 to Express
Scripts, Inc.’s Current Report on Form 8-K filed March 7, 2006, File No. 000-20199.
10.8(3) Form of Restricted Stock Unit Agreement used with respect to grants of restricted stock units by Express Scripts,
Inc. under the Express Scripts, Inc. 2000 Long-Term Incentive Plan, incorporated by reference to Exhibit No. 10.4
to Express Scripts, Inc.’s Current Report on Form 8-K filed March 3, 2009, File No. 000-20199.
10.9(3) Express Scripts, Inc. 2011 Long-Term Incentive Plan (as amended and restated effective April 2, 2012),
incorporated by reference to Exhibit 10.1 to Express Scripts Holding Company’s Quarterly Report on Form 10-Q
for the quarter ended June 30, 2012.